Treatment of undifferentiated spondyloarthropathies is

Remember that there are many types of undifferentiated joint diseases, but they all cause serious damage to the spine. When there are abnormalities in the spine, there will generally be some symptoms. Everyone must pay close attention and get checked and treated as soon as possible.

There are many types of undifferentiated spondyloarthropathy, but they all cause great harm to the human body. Of course, many times illness strikes silently, so it’s important to detect the signs in yourself in time. Let’s study it carefully below.

Some patients with undifferentiated spondyloarthropathy only have mild symptoms and signs and do not need special treatment, or may receive physical therapy to improve symptoms. Patients with obvious inflammation can choose non-steroidal anti-inflammatory drugs.

For some patients with severe arthritis symptoms and enthesopathy, corticosteroids can be injected into the affected joint or at the site of inflammation. When sacroiliitis is severe and conventional treatment is ineffective, corticosteroids can be injected into the inflammatory sacroiliac joint under CT guidance, which has been reported to achieve significant therapeutic effects.

For a small number of patients with acute or highly active inflammation, systemic corticosteroids may be used, but the dosage and course of treatment should be strictly controlled.

For chronic patients with a long course of disease, persistent arthritis and enthesopathy, if nonsteroidal anti-inflammatory drugs alone cannot completely control the symptoms, immunosuppressants can be added.

Sulfasalazine can achieve better results in patients with undifferentiated spondyloarthropathy with inflammatory bowel disease. The possible mechanism is that sulfasalazine treats inflammatory bowel disease by restoring normal intestinal permeability and inhibiting antigens from entering the damaged intestinal wall, but it has no preventive effect. In addition, whether the early use of sulfasalazine can improve the course of the disease and prognosis is still unclear and needs further study. As for the general situation of clinical treatment in China, doctors are often willing to choose sulfasalazine to treat undifferentiated spondyloarthropathy, which may be related to the moderate price of the drug and its generally high safety.